Medpace Holdings (MEDP) Capital Expenditures (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Capital Expenditures data on file, last reported at $23.9 million in Q2 2026.

• Quarterly Capital Expenditures rose 291.15% year-over-year to $23.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $46.0 million (up 34.09% YoY) and the FY2025 annual result came in at $31.4 million, down 14.21% from the prior year.
• Capital Expenditures rose to $23.9 million in Q2 2026, from $6.8 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $23.9 million in Q2 2026 to a low of $4.5 million in Q4 2025.
• A 5-year average of $9.6 million and a median of $9.2 million in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2025 — Capital Expenditures sank 52.51% — and 2026, when it surged 291.15%.
• Tracing MEDP's Capital Expenditures over 5 years: stood at $9.2 million in 2022, then rose by 8.04% to $10.0 million in 2023, then slipped by 23.46% to $7.6 million in 2024, then slumped by 40.65% to $4.5 million in 2025, then jumped by 427.14% to $23.9 million in 2026.
• The last three Capital Expenditures figures came in at $23.9 million (Q2 2026), $6.8 million (Q1 2026), and $4.5 million (Q4 2025), per Business Quant data.